Highest-materiality recent filing
UHT Q2 2026 net income $5.9M ($0.43 EPS) vs $4.5M; FFO $0.90; credit facility increased to $475M
Q2 2026 net income $5.9M ($0.43 diluted EPS) vs $4.5M ($0.32) in Q2 2025; adjusted net income $5.2M ($0.37).
UHT grants restricted stock to executives; shareholders re-elect trustees
Granted 6,247 restricted shares to Chairman/CEO Miller, 3,631 each to CFO Boyle and SVP Ramagano, and 1,598 to VP Peterson; vest in 2 years with accrued dividends.
UHT Q1 2026 EPS $0.36, FFO $0.88; credit line upsized to $475M
Net income $5.0M ($0.36/shr) vs $4.8M ($0.34/shr) in Q1 2025, up $0.02.
UHT enters $50M incremental term loan amendment; minimum tangible net worth set at $100M
New $50M incremental term loan under existing credit facility; matures Sept 30, 2028.
UHT Q4 net income $4.3M ($0.31 EPS), down YoY; FFO flat $0.85/share; new $34M MOB development
Q4 net income $4.3M ($0.31 diluted) vs $4.7M ($0.34) a year ago; FY 2025 net income $17.6M ($1.27) vs $19.2M ($1.39).
UHT reports Q3 net income of $0.29/sh; FFO $0.88/sh; announces $34M MOB development
Q3 net income $4.0M ($0.29/sh) flat YoY; FFO rose to $12.2M ($0.88/sh) from $11.3M ($0.82/sh).
UHT Q2 net income down to $4.5M ($0.32/sh); FFO per share $0.85 vs $0.90 YoY
Net income $4.5M, EPS $0.32 versus $5.3M ($0.38) in Q2 2024, down $784K.
UHT grants restricted stock to CEO Miller and other execs; annual meeting re-elects trustees
CEO Miller received 6,021 restricted shares; CFO Boyle and VP Ramagano each 3,499; VP Peterson 1,540.
Universal Health Realty Income Trust Q1 EPS $0.34 vs $0.38; FFO $0.86 vs $0.90
Q1 2025 net income $4.8M ($0.34 diluted EPS) down from $5.3M ($0.38) in Q1 2024.
UHT Q4 net income $4.7M ($0.34/dil) up from $3.6M; FFO $11.8M ($0.85/dil)
Net income Q4 2024: $4.7M ($0.34/dil) vs $3.6M ($0.26/dil) in Q4 2023; full year $19.2M ($1.39/dil) vs $15.4M ($1.11/dil).
UHT Q3 net income $4.0M ($0.29 EPS) vs $3.9M ($0.28); FFO $0.82
Net income $4.0M ($0.29 diluted EPS) vs $3.9M ($0.28) in Q3 2023; FFO $11.3M ($0.82) vs $11.2M ($0.81).
UHT enters $425M credit facility ($300M revolver + $125M term loan) maturing Sept 2028
New Second Amended and Restated Credit Agreement increases total commitments to $425M from prior $300M revolver.
UHT Q2 2024 net income $0.38/share, up 52% YoY; FFO $0.90/share vs $0.77
Q2 net income $5.3M ($0.38/diluted) vs $3.5M ($0.25) in Q2 2023; FFO $12.4M ($0.90) vs $10.6M ($0.77).
UHT shareholders re-elect trustees, approve pay votes and stock plan amendment
Elected Marc D. Miller (7.79M for) and Gayle L. Capozzalo (8.08M for) as Class II trustees for three-year terms.
UHT Q1 2024 net income $5.3M ($0.38/sh), FFO $12.4M ($0.90/sh), dividend $0.725/sh
Net income $5.3M ($0.38 diluted EPS) vs $4.5M ($0.32) in Q1 2023, up $0.06/sh.
UHT Q4 2023 EPS $0.26 vs $0.41, FFO $0.82 vs $0.90; full year EPS $1.11 vs $1.53
Q4 net income $3.6M ($0.26 diluted) vs $5.6M ($0.41) in Q4 2022.
Q3 net income down to $3.9M ($0.28 diluted EPS) from $4.8M; FFO $0.81 vs $0.86
Net income $3.9M ($0.28 diluted) vs $4.8M ($0.35) a year ago; decrease driven by interest expense increase.
UHT Q2 net income falls to $3.5M ($0.25/diluted), FFO drops to $0.77/share
Net income $3.5M vs $5.2M in Q2 2022; diluted EPS $0.25 vs $0.38.
UHT grants restricted stock to execs; shareholders re-elect trustees, approve say-on-pay
Alan B. Miller awarded 4,612 restricted shares; CFO C. Boyle and SVP Ramagano each 2,682 shares; VP Peterson 1,180 shares.
UHT amends credit agreement to replace LIBOR with Adjusted Term SOFR as benchmark rate
First Amendment signed May 15, 2023 to the existing $450M credit agreement dated July 2, 2021.
UHT Q1 2023 net income $4.5M ($0.32) vs $5.4M ($0.39) YoY; FFO $0.82 vs $0.90
Net income down $946k to $4.5M ($0.32 diluted) from $5.4M ($0.39) in Q1 2022.
UHT Q4 2022 net income $5.6M ($0.41/diluted); FFO $0.90/diluted, down from $0.93 YoY
Adjusted net income flat at $5.6M ($0.41/diluted) vs Q4 2021 after excluding $86M gain on divestitures.
Universal Health Realty appoints Rebecca Guzman as independent trustee
Board expanded to seven; Rebecca Guzman appointed as Class III Trustee, term through 2025 Annual Meeting.
UHT Q3 net income $4.8M ($0.35 EPS), down from $5.3M ($0.39) YoY; FFO $0.86 vs $0.92
Net income $4.8M ($0.35 diluted EPS), down $0.5M YoY; FFO $11.8M ($0.86 diluted), down from $12.6M ($0.92).
UHT Q2 2022 net income falls to $5.2M ($0.38/diluted) from $6.6M; FFO down to $0.88 from $0.92
Net income $5.2M ($0.38/diluted) vs $6.6M ($0.48) in Q2 2021; adjusted net income virtually flat at $0.39/diluted.
Stockholders elect Domb and Morey as Class III trustees, approve compensation, ratify KPMG
Michael Allan Domb re-elected with 8,805,209 votes for; James P. Morey re-elected with 7,227,765 votes for.
Universal Health Realty Q1 net income $5.4M ($0.39), FFO $0.90; sees $1.9M in vacant facility costs
Net income $5.4M ($0.39 diluted EPS) vs $5.6M ($0.41) in Q1 2021; FFO $12.4M ($0.90) vs $12.7M ($0.92).
UHT Q4 2021 FFO $0.93, adjusted EPS $0.41; closed $82.4M asset swap with UHS
Q4 net income $91.6M ($6.65/sh) includes $86.0M gain on divestitures; adjusted net income $5.6M ($0.41) vs $5.0M ($0.36) YoY.
UHT swaps Inland Valley campus for two hospital properties; new 12-year leases with UHS subsidiaries
Sold Inland Valley Campus to UHS at $79.6M fair value; acquired ARMC ($57.7M) and Canyon Creek ($24.7M) plus $2.8M cash.
Net income of $5.3M ($0.39/diluted) vs $5.2M ($0.38) in Q3 2020; FFO $12.6M ($0.92) vs $11.9M ($0.86).
UHT Q2 net income $6.6M ($0.48 EPS) vs $4.7M ($0.34) YoY; FFO $0.92/share
Q2 net income $6.6M ($0.48 diluted EPS) vs $4.7M ($0.34) YoY; adjusted net income $5.3M ($0.39) excl. $1.3M gain.
UHT enters $375M revolving credit facility due July 2025; refinances $258.2M
New $375M unsecured revolving credit facility, matures July 2, 2025; includes $50M accordion feature.
On November 30, 2022, the Board of Trustees of Universal Health Realty Income Trust (the “Trust”) expanded the Board of Trustees to seven members and appointed Rebecca A. Guzman to serve as a Class III Trustee of the Trust.
Max materiality 0.75 · Median 0.57 · Most common event earnings